BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38402378)

  • 1. Acute venous thromboembolism plasma and red blood cell metabolomic profiling reveals potential new early diagnostic biomarkers: observational clinical study.
    Febra C; Saraiva J; Vaz F; Macedo J; Al-Hroub HM; Semreen MH; Maio R; Gil V; Soares N; Penque D
    J Transl Med; 2024 Feb; 22(1):200. PubMed ID: 38402378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of three observational, prospective cohort studies including biobanking to evaluate and improve diagnostics, management strategies and risk stratification in venous thromboembolism: the VTEval Project.
    Frank B; Ariza L; Lamparter H; Grossmann V; Prochaska JH; Ullmann A; Kindler F; Weisser G; Walter U; Lackner KJ; Espinola-Klein C; Münzel T; Konstantinides SV; Wild PS;
    BMJ Open; 2015 Jul; 5(7):e008157. PubMed ID: 26133379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Biomarkers and Identification of Resilient Metabolic Disruptions in Patients With Venous Thromboembolism Using a Metabolic Systems Approach.
    Fraser K; Roy NC; Goumidi L; Verdu A; Suchon P; Leal-Valentim F; Trégouët DA; Morange PE; Martin JC
    Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2527-2538. PubMed ID: 32757649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Value for Increased Red Blood Cell Distribution Width in Unprovoked Acute Venous Thromboembolism at the Emergency Department.
    Febra C; Spinu V; Ferreira F; Gil V; Maio R; Penque D; Macedo A
    Clin Appl Thromb Hemost; 2023; 29():10760296231193397. PubMed ID: 37691287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical features of patients with venous thromboembolism: 177 case analysis in 10 years].
    Gong B; Xu Q; Pang Y; Hu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Apr; 31(4):453-457. PubMed ID: 31109420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous Thromboembolism in Necrotizing Pancreatitis: an Underappreciated Risk.
    Roch AM; Maatman TK; Carr RA; Colgate CL; Ceppa EP; House MG; Lopes J; Nakeeb A; Schmidt CM; Zyromski NJ
    J Gastrointest Surg; 2019 Dec; 23(12):2430-2438. PubMed ID: 30734182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
    Robertson L; Yeoh SE; Broderick C; Stansby G; Agarwal R
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD010837. PubMed ID: 30407621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
    Robertson L; Yeoh SE; Stansby G; Agarwal R
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010837. PubMed ID: 28832905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation of platelet function in clinical phenotypes of acute venous thromboembolism - Results from the GMP-VTE project.
    Panova-Noeva M; Wagner B; Nagler M; Koeck T; Ten Cate V; Eggebrecht L; Prochaska JH; Meyer I; Gerdes C; Spronk HM; Lackner KJ; Ten Cate H; Leineweber K; Heitmeier S; Konstantinides S; Wild PS
    J Thromb Haemost; 2022 Mar; 20(3):705-715. PubMed ID: 34784445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in duration of anticoagulation after pulmonary embolism and deep vein thrombosis: Findings from the SWIss Venous ThromboEmbolism Registry (SWIVTER).
    Wenger N; Sebastian T; Beer JH; Mazzolai L; Aujesky D; Hayoz D; Engelberger RP; Korte W; Voci D; Kucher N; Barco S; Spirk D
    Thromb Res; 2022 Dec; 220():65-71. PubMed ID: 36272334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review and meta-analysis of incidence, prognosis, and laboratory indicators of venous thromboembolism in hospitalized patients with coronavirus disease 2019.
    Liu Y; Cai J; Wang C; Jin J; Qu L
    J Vasc Surg Venous Lymphat Disord; 2021 Sep; 9(5):1099-1111.e6. PubMed ID: 33529719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receipt of anticoagulation after venous thromboembolism diagnoses during delivery hospitalizations.
    O'Shaugnessy F; Syeda SK; Huang Y; D'Alton ME; Wen T; Wright JD; Friedman AM
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6353-6355. PubMed ID: 33855935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism in hospital emergency room. A retrospective study on climatic effect.
    Signorelli SS; Oliveri Conti G; Carpinteri G; Lumera G; Fiore M; Dattilo G; Gaudio A; Ferrante M
    Environ Res; 2021 Jun; 197():110950. PubMed ID: 33737078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of mannose-binding lectin and future risk of venous thromboembolism.
    Liang RA; Høiland II; Ueland T; Aukrust P; Snir O; Hindberg K; Braekkan SK; Garred P; Mollnes TE; Hansen JB
    J Thromb Haemost; 2019 Oct; 17(10):1661-1669. PubMed ID: 31220397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of soluble P selectin in the diagnosis of venous thromboembolism.
    Antonopoulos CN; Sfyroeras GS; Kakisis JD; Moulakakis KG; Liapis CD
    Thromb Res; 2014 Jan; 133(1):17-24. PubMed ID: 24012101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does tranexamic acid increase venous thromboembolism risk among trauma patients? A prospective multicenter analysis across 17 level I trauma centers.
    Knowlton LM; Arnow K; Trickey AW; Sauaia A; Knudson MM
    Injury; 2023 Nov; 54(11):111008. PubMed ID: 37669883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma lipopolysaccharide-binding protein is a biomarker for future venous thromboembolism: Results from discovery and validation studies.
    Jensen SB; Latysheva N; Hindberg K; Ueland T
    J Intern Med; 2022 Sep; 292(3):523-535. PubMed ID: 35426199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Pharmacologic Prophylaxis on Venous Thromboembolism After Radical Prostatectomy: The PREVENTER Randomized Clinical Trial.
    Patel HD; Faisal FA; Trock BJ; Joice GA; Schwen ZR; Pierorazio PM; Johnson MH; Bivalacqua TJ; Han M; Gorin MA; Carter HB; Partin AW; Pavlovich CP; Allaf ME
    Eur Urol; 2020 Sep; 78(3):360-368. PubMed ID: 32444264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study.
    Kyrle PA; Kammer M; Eischer L; Weltermann A; Minar E; Hirschl M; Heinze G; Eichinger S
    J Thromb Haemost; 2016 Dec; 14(12):2402-2409. PubMed ID: 27696701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in patients with unprovoked VTE.
    Robertson L; Yeoh SE; Stansby G; Agarwal R
    Cochrane Database Syst Rev; 2015 Mar; (3):CD010837. PubMed ID: 25749503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.